The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Diabetes and advanced glycation endproducts
Abstract
Vlassara H, Palace MR (Department of Geriatrics, Division of Experimental Diabetes and Ageing, Mount Sinai School of Medicine, and Department of Medicine, Division of Endocrinology, Mount Sinai School of Medicine, NY, USA). Diabetes and Advanced Glycation Endproducts. J Intern Med 2002; 251: 87–101. Bio‐reactive advanced glycation endproducts (AGE) alter the structure and function of molecules in biological systems and increase oxidative stress. These adverse effects of both exogenous and endogenously derived AGE have been implicated in the pathogenesis of diabetic complications and changes associated with ageing including atherosclerosis, renal, eye and neurological disease. Specific AGE receptors and nonreceptor mechanisms contribute to these processes but also assist in the removal and degradation of AGE. The final disposal of AGE depends on renal clearance. Promising pharmacologic strategies to prevent AGE formation, reduce AGE toxicity, and/or inactivate AGE are under investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Self-citationGoldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.168 · Cited by 1,290
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Self-citationImpaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,072
Gardella, S., Andrei, C., Ferrera, D., Lotti, L. V., Torrisi, M. R., Bianchi, M. E., & Rubartelli, A. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf198 · Cited by 926
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Self-citationVlassara, H., Bucala, R., & Striker, L. J. (1994) · PubMed · Cited by 848
Self-citationDu, X., Matsumura, T., Edelstein, D., Rossetti, L., Zsengellér, Z., Szabó, C., & Brownlee, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18127 · Cited by 832
Fu, M.-X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., & Thorpe, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9982 · Cited by 822
Sima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806
Self-citationKoschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Self-citationSchmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
Nonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived Proteins
Monnier, V. M., & Cerami, A. (1981) · Science · doi:10.1126/science.6779377 · Cited by 764
Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker
Kass, D. A., Shapiro, E. P., Kawaguchi, M., Capriotti, A. R., Scuteri, A., deGroof, R. C., & Lakatta, E. G. (2001) · Circulation · doi:10.1161/hc3801.097806 · Cited by 727
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Self-citationHuttunen, H. J., Fages, C., & Rauvala, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19919 · Cited by 628
Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling
Vlassara, H., Brownlee, M., Manogue, K. R., Dinarello, C. A., & Pasagian, A. (1988) · Science · doi:10.1126/science.3259727 · Cited by 597
Self-citationSalomaa, V., Riley, W., Kark, J. D., Nardo, C., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 582
Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
Bucala, R., Makita, Z., Koschinsky, T., Cerami, A., & Vlassara, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6434 · Cited by 571
Self-citationTobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
Self-citationBasta, G., Lazzerini, G., Massaro, M., Simoncini, T., Tanganelli, P., Fu, C., Kislinger, T., Stern, D. M., Schmidt, A. M., & De Caterina, R. (2002) · Circulation · doi:10.1161/hc0702.104183 · Cited by 544
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.
Hammes, H. P., Martin, S., Federlin, K., Geisen, K., & Brownlee, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11555 · Cited by 524
Miyata, T., van Ypersele de Strihou, C., Kurokawa, K., & Baynes, J. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00302.x · Cited by 518
Shinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Yan, S. F., Ramasamy, R., Naka, Y., & Schmidt, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000103862.26506.3d · Cited by 513
How hyperglycemia promotes atherosclerosis: molecular mechanisms
Aronson, D., & Rayfield, E. J. (2002) · Cardiovascular Diabetology · doi:10.1186/1475-2840-1-1 · Cited by 504
Progression of Incipient Diabetic Retinopathy During Good Glycemic Control
Engerman, R. L., & Kern, T. S. (1987) · Diabetes · doi:10.2337/diab.36.7.808 · Cited by 490
Bucala, R., Makita, Z., Vega, G., Grundy, S., Koschinsky, T., Cerami, A., & Vlassara, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9441 · Cited by 474
Self-citationAn agent cleaving glucose-derived protein crosslinks in vitro and in vivo
Vasan, S., Zhang, X., Zhang, X., Kapurniotu, A., Bernhagen, J., Teichberg, S., Basgen, J., Wagle, D., Shih, D., Terlecky, I., et al. (1996) · Nature · doi:10.1038/382275a0 · Cited by 466
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 462
Self-citationZeiher, A. M., Fisslthaler, B., Schray-Utz, B., & Busse, R. (1995) · Circulation Research · doi:10.1161/01.res.76.6.980 · Cited by 462
Bolton, W. K., Cattran, D. C., Williams, M. E., Adler, S. G., Appel, G. B., Cartwright, K., Foiles, P. G., Freedman, B. I., Raskin, P., Ratner, R. E., et al. (2004) · American Journal of Nephrology · doi:10.1159/000075627 · Cited by 461
Candido, R., Forbes, J. M., Thomas, M. C., Thallas, V., Dean, R. G., Burns, W. C., Tikellis, C., Ritchie, R. H., Twigg, S. M., Cooper, M. E., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000065620.39919.20 · Cited by 448
Soulis-Liparota, T., Cooper, M., Papazoglou, D., Clarke, B., & Jerums, G. (1991) · Diabetes · doi:10.2337/diab.40.10.1328 · Cited by 447
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Mills, J. L., Baker, L., & Goldman, A. S. (1979) · Diabetes · doi:10.2337/diab.28.4.292 · Cited by 435
Breakers of advanced glycation end products restore large artery properties in experimental diabetes
Wolffenbuttel, B. H. R., Boulanger, C. M., Crijns, F. R. L., Huijberts, M. S. P., Poitevin, P., Swennen, G. N. M., Vasan, S., Egan, J. J., Ulrich, P., Cerami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4630 · Cited by 434
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Hasche, H., Lobisch, M., Schütte, K., Kerum, G., & Malessa, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1296 · Cited by 432
Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421
Self-citationDiabetic cataract formation: potential role of glycosylation of lens crystallins.
Stevens, V. J., Rouzer, C. A., Monnier, V. M., & Cerami, A. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2918 · Cited by 412
Miyata, T., Oda, O., Inagi, R., Iida, Y., Araki, N., Yamada, N., Horiuchi, S., Taniguchi, N., Maeda, K., & Kinoshita, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116696 · Cited by 398
Malformations in infants of diabetic mothers
Mills, J. L. (1982) · Teratology · doi:10.1002/tera.1420250316 · Cited by 392
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat
Degenhardt, T. P., Alderson, N. L., Arrington, D. D., Beattie, R. J., Basgen, J. M., Steffes, M. W., Thorpe, S. R., & Baynes, J. W. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00207.x · Cited by 378
Vlassara, H., Fuh, H., Makita, Z., Krungkrai, S., Cerami, A., & Bucala, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12043 · Cited by 377
Self-citationReactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
Makita, Z., Bucala, R., Rayfield, E. J., Fuh, H., Manogue, K. R., Cerami, A., Viassara, H., Friedman, E. A., Kaufman, A. M., Korbet, S. M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92935-1 · Cited by 373
Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Müller, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1481 · Cited by 371
Central role of RAGE-dependent neointimal expansion in arterial restenosis
Sakaguchi, T., Yan, S. F., Yan, S. D., Belov, D., Rong, L. L., Sousa, M., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17115 · Cited by 367
Giardino, I., Edelstein, D., & Brownlee, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117296 · Cited by 364
Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine
Edelstein, D., & Brownlee, M. (1992) · Diabetes · doi:10.2337/diab.41.1.26 · Cited by 360
Paul, R. G., & Bailey, A. J. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00079-9 · Cited by 359
Mills, J. L., Knopp, R. H., Simpson, J. L., Jovanovic-Peterson, L., Metzger, B. E., Holmes, L. B., Aarons, J. H., Brown, Z., Reed, G. F., Bieber, F. R., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803173181104 · Cited by 358
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.4.252 · Cited by 358
Anderson, M. M., Requena, J. R., Crowley, J. R., Thorpe, S. R., & Heinecke, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3042 · Cited by 349
Miyata, T., Inagi, R., Iida, Y., Sato, M., Yamada, N., Oda, O., Maeda, K., & Seo, H. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117002 · Cited by 345
The Lens: Development, Proteins, Metabolism and Cataract
HARDING, J. J., & CRABBE, M. J. C. (1984) · The Eye · doi:10.1016/b978-0-12-206921-5.50008-8 · Cited by 345
Li, Y. M., Mitsuhashi, T., Wojciechowicz, D., Shimizu, N., Li, J., Stitt, A., He, C., Banerjee, D., & Vlassara, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11047 · Cited by 341
Self-citationUribarri, J., Peppa, M., Cai, W., Goldberg, T., Lu, M., He, C., & Vlassara, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051593.41395.b9 · Cited by 331
Self-citationSchmidt, A. M., Hasu, M., Popov, D., Zhang, J. H., Chen, J., Yan, S. D., Brett, J., Cao, R., Kuwabara, K., & Costache, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8807 · Cited by 326
Stitt, A. W., Li, Y. M., Gardiner, T. A., Bucala, R., ARCHER, D. B., & Vlassara, H. (1997) · Europe PMC (PubMed Central) · Cited by 324
Self-citationRecent Progress in Advanced Glycation End Products and Diabetic Complications
Vlassara, H. (1997) · Diabetes · doi:10.2337/diab.46.2.s19 · Cited by 318
Self-citationMahley, R. W., Innerarity, T. L., Weisgraber, K. H., & Oh, S. Y. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109518 · Cited by 316
Monnier, V. M., Sell, D. R., Nagaraj, R. H., Miyata, S., Grandhee, S., Odetti, P., & Ibrahim, S. A. (1992) · Diabetes · doi:10.2337/diab.41.2.s36 · Cited by 309
Chelating Activity of Advanced Glycation End-product Inhibitors
Price, D. L., Rhett, P. M., Thorpe, S. R., & Baynes, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108196200 · Cited by 308
Hofmann, S. M., Dong, H.-J., Li, Z., Cai, W., Altomonte, J., Thung, S. N., Zeng, F., Fisher, E. A., & Vlassara, H. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2082 · Cited by 296
Self-citationKume, S., Takeya, M., Mori, T., Araki, N., Suzuki, H., Horiuchi, S., Kodama, T., Miyauchi, Y., & Takahashi, K. (1995) · Europe PMC (PubMed Central) · Cited by 295
Advanced glycation end products: A nephrologist's perspective
Raj, D. S. C., Choudhury, D., Welbourne, T. C., & Levi, M. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70189-2 · Cited by 290
Miyata, T., van Ypersele de Strihou, C., Ueda, Y., Ichimori, K., Inagi, R., Onogi, H., Ishikawa, N., Nangaku, M., & Kurokawa, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032418.67267.f2 · Cited by 290
Sell, D. R., & Monnier, V. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114449 · Cited by 289
Nakamura, Y., Horii, Y., Nishino, T., Shiiki, H., Sakaguchi, Y., Kagoshima, T., Dohi, K., Makita, Z., Vlassara, H., & Bucala, R. (1993) · PubMed Central · Cited by 283
Self-citationTaniwaki, H., Kawagishi, T., Emoto, M., Shoji, T., Kanda, H., Maekawa, K., Nishizawa, Y., & Morii, H. (1999) · Diabetes Care · doi:10.2337/diacare.22.11.1851 · Cited by 283
Quehenberger, P., Bierhaus, A., Fasching, P., Muellner, C., Klevesath, M., Hong, M., Stier, G., Sattler, M., Schleicher, E., Speiser, W., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1561 · Cited by 283
Diabetes as an atherogenic factor
Ruderman, N. B., & Haudenschild, C. (1984) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(84)90011-2 · Cited by 282
Pacher, P., Liaudet, L., Soriano, F. G., Mabley, J. G., Szabó, E., & Szabó, C. (2002) · Diabetes · doi:10.2337/diabetes.51.2.514 · Cited by 281
Vinik, A. I., Holland, M. T., Beau, J. M. L., Liuzzi, F. J., Stansberry, K. B., & Colen, L. B. (1992) · Diabetes Care · doi:10.2337/diacare.15.12.1926 · Cited by 281
Pharmacological Inhibition of Diabetic Retinopathy
Kern, T. S., & Engerman, R. L. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1636 · Cited by 277
Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. M., Jerums, G., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3274 · Cited by 277
Steinbrecher, U. P., & Witztum, J. L. (1984) · Diabetes · doi:10.2337/diab.33.2.130 · Cited by 272
Kilhovd, B. K., Berg, T. J., Birkeland, K. I., Thorsby, P., & Hanssen, K. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1543 · Cited by 269
Kirstein, M., Aston, C., Hintz, R., & Vlassara, H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115879 · Cited by 265
Self-citationForbes, J. M., Thallas, V., Thomas, M. C., Founds, H. W., Burns, W. C., Jerums, G., & Cooper, M. E. (2003) · The FASEB Journal · doi:10.1096/fj.02-1102fje · Cited by 263
Candido, R., Jandeleit-Dahm, K. A., Cao, Z., Nesteroff, S. P., Burns, W. C., Twigg, S. M., Dilley, R. J., Cooper, M. E., & Allen, T. J. (2002) · Circulation · doi:10.1161/01.cir.0000021122.63813.32 · Cited by 261
Giardino, I., Fard, A. K., Hatchell, D. L., & Brownlee, M. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1114 · Cited by 258
Araki, N., Higashi, T., Mori, T., Shibayama, R., Kawabe, Y., Kodama, T., Takahashi, K., Shichiri, M., & Horiuchi, S. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0408h.x · Cited by 248
Gugliucci, A., & Bendayan, M. (1996) · Diabetologia · doi:10.1007/bf00403957 · Cited by 247
Vlassara, H., Fuh, H., Donnelly, T., & Cybulsky, M. (1995) · Molecular Medicine · doi:10.1007/bf03401582 · Cited by 244
Self-citationOhgami, N., Nagai, R., Ikemoto, M., Arai, H., Kuniyasu, A., Horiuchi, S., & Nakayama, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006545200 · Cited by 244
Skolnik, E. Y., Yang, Z., Makita, Z., Radoff, S., Kirstein, M., & Vlassara, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.931 · Cited by 244
Self-citationMackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2029 · Cited by 242
Cai, W., Gao, Q.-D., Zhu, L., Peppa, M., He, C., & Vlassara, H. (2002) · Molecular Medicine · doi:10.1007/bf03402014 · Cited by 235
Self-citationNakamura, S., Makita, Z., Ishikawa, S., Yasumura, K., Fujii, W., Yanagisawa, K., Kawata, T., & Koike, T. (1997) · Diabetes · doi:10.2337/diab.46.5.895 · Cited by 235
Fogelman, A. M., Haberland, M. E., Seager, J., Hokom, M., & Edwards, P. A. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40672-8 · Cited by 230
Renal function changes in diabetes.
Ce, M. (1976) · PubMed · Cited by 226
Therapeutic potential of breakers of advanced glycation end product–protein crosslinks
Vasan, S., Foiles, P., & Founds, H. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.016 · Cited by 221
Nonenzymatic Glycosylation Products on Collagen Covalently Trap Low-Density Lipoprotein
Brownlee, M., Vlassara, H., & Cerami, A. (1985) · Diabetes · doi:10.2337/diab.34.9.938 · Cited by 219
Self-citationSeftel, A. D., Vaziri, N. D., Ni, Z., Razmjouei, K., Fogarty, J., Hampel, N., Polak, J., Wang, R.-Z., Ferguson, K., Block, C., et al. (1997) · Urology · doi:10.1016/s0090-4295(97)00512-8 · Cited by 216
Capillary number and percentage closed in human diabetic sural nerve.
Dyck, P. J., Hansen, S., Karnes, J., O'Brien, P., Yasuda, H., Windebank, A., & Zimmerman, B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.8.2513 · Cited by 215
Nonenzymatic glucosylation and glucose-dependent cross-linking of protein.
Eble, A. S., Thorpe, S. R., & Baynes, J. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44682-5 · Cited by 214
Advanced glycation end products, oxidant stress and vascular lesions
CHAPPEY, O., DOSQUET, C., WAUTIER, M., & WAUTIER, J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.710624.x · Cited by 214
Berg, T. J., Snorgaard, O., Faber, J., Torjesen, P. A., Hildebrandt, P., Mehlsen, J., & Hanssen, K. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1186 · Cited by 212
Bucala, R., Model, P., & Cerami, A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.1.105 · Cited by 211
Yamagishi, S.-I., Amano, S., Inagaki, Y., Okamoto, T., Koga, K., Sasaki, N., Yamamoto, H., Takeuchi, M., & Makita, Z. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6312 · Cited by 209
Murata, T., Nagai, R., Ishibashi, T., Inomata, H., Ikeda, K., & Horiuchi, S. (1997) · Diabetologia · doi:10.1007/s001250050747 · Cited by 201
Uribarri, J., Peppa, M., Cai, W., Goldberg, T., Lu, M., Baliga, S., Vassalotti, J. A., & Vlassara, H. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00779-0 · Cited by 197
Self-citationNiwa, T., Katsuzaki, T., Miyazaki, S., Miyazaki, T., Ishizaki, Y., Hayase, F., Tatemichi, N., & Takei, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119285 · Cited by 196
Haitoglou, C. S., Tsilibary, E. C., Brownlee, M., & Charonis, A. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42287-9 · Cited by 195
Neumann, A., Schinzel, R., Palm, D., Riederer, P., & Münch, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00731-0 · Cited by 195
Statistics on Blindness in the Model Reporting Area 1969–1970
KAHN, H. A., & MOOR-HEAD. DHEW, H. B. (1973) · Optometry and Vision Science · doi:10.1097/00006324-197312000-00022 · Cited by 194
Yang, Z., Makita, Z., Horii, Y., Brunelle, S., Cerami, A., Sehajpal, P., Suthanthiran, M., & Vlassara, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.515 · Cited by 192
Self-citationMiyata, T., Ueda, Y., Yamada, Y., Izuhara, Y., Wada, T., Jadoul, M., Saito, A., Kurokawa, K., & van Ypersele de Strihou, C. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9122349 · Cited by 188
AGEs in foods: do they play a role in uremia?
Henle, T. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.16.x · Cited by 184
Accelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice
PUGLIESE, G., PRICCI, F., IACOBINI, C., LETO, G., AMADIO, L., BARSOTTI, P., FRIGERI, L., HSU, D. K., VLASSARA, H., LIU, F.-T., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0006com · Cited by 184
Self-citationVascular Reactivity to Angiotensin II and to Norepinephrine in Diabetic Subjects
Christlieb, A. R., Janka, H.-U., Kraus, B., Gleason, R. E., Icasas-Cabral, E. A., Aiello, L. M., Cabral, B. V., & Solano, A. (1976) · Diabetes · doi:10.2337/diab.25.4.268 · Cited by 183
Collagen Aging In Vitro by Nonenzymatic Glycosylation and Browning
Kohn, R. R., Cerami, A., & Monnier, V. M. (1984) · Diabetes · doi:10.2337/diab.33.1.57 · Cited by 183
Receptor for AGE (RAGE) Mediates Neointimal Formation in Response to Arterial Injury
Zhou, Z., Wang, K., Penn, M. S., Marso, S. P., Lauer, M. A., Forudi, F., Zhou, X., Qu, W., Lu, Y., Stern, D. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000063577.32819.23 · Cited by 173
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
Lin, R.-Y., Choudhury, R. P., Cai, W., Lu, M., Fallon, J. T., Fisher, E. A., & Vlassara, H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00050-9 · Cited by 171
Self-citationAtherosclerosis and diabetes: The rage connection
Schmidt, A. M., & Stern, D. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0082-4 · Cited by 167
Renoprotective effects of a novel inhibitor of advanced glycation
Forbes, J. M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D. M., Vasan, S., Wagle, D., Jerums, G., & Cooper, M. E. (2001) · Diabetologia · doi:10.1007/s001250051587 · Cited by 161
Watkins, N. G., Thorpe, S. R., & Baynes, J. W. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85131-1 · Cited by 158
Takata, K., Horiuchi, S., Araki, N., Shiga, M., Saitoh, M., & Morino, Y. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68112-8 · Cited by 154
Vlassara, H., Brownlee, M., & Cerami, A. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.4.1301 · Cited by 154
Self-citationAdverse effects of dietary glycotoxins on wound healing in genetically diabetic mice
Peppa, M., Brem, H., Ehrlich, P., Zhang, J.-G., Cai, W., Li, Z., Croitoru, A., Thung, S., & Vlassara, H. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2805 · Cited by 153
Hudson, B. I., Stickland, M. H., & Grant, P. J. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1155 · Cited by 153
Li, Y. M., Tan, A. X., & Vlassara, H. (1995) · Nature Medicine · doi:10.1038/nm1095-1057 · Cited by 153
Self-citationUltrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy
Makino, H., Shikata, K., Hironaka, K., Kushiro, M., Yamasaki, Y., Sugimoto, H., Ota, Z., Araki, N., & Horiuchi, S. (1995) · Kidney International · doi:10.1038/ki.1995.322 · Cited by 148
Cameron, N. E., & Cotter, M. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118104 · Cited by 147
Tsilibary, E. C., CHARONIS, A. S., Reger, L. A., Wohlhueter, R. M., & Furcht, L. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68925-2 · Cited by 147
Bucala, R., Mitchell, R., Arnold, K. S., Innerarity, T. L., Vlassara, H., & Cerami, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10828 · Cited by 147
Self-citationGlycation and Glycoxidation of Histones by ADP-ribose
Cervantes-Laurean, D., Jacobson, E. L., & Jacobson, M. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10461 · Cited by 145
Huijberts, M. S., Wolffenbuttel, B. H. R., Struijker-Boudier, H. A. J., Crijns, F. R. L., Kruseman, A. C. N., Poitevin, P., & Levy, B. I. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116716 · Cited by 140
Papanastasiou, P., Grass, L., Rodela, H., Patrikarea, A., Oreopoulos, D. G., & Diamandis, E. P. (1994) · Kidney International · doi:10.1038/ki.1994.262 · Cited by 139
Palinski, W., Koschinsky, T., Butler, S. W., Miller, E. R., Vlassara, H., Cerami, A., & Witztum, J. L. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.5.571 · Cited by 138
Self-citationStitt, A. W., Moore, J. E., Sharkey, J. A., Murphy, G., Simpson, D. A. C., Bucala, R., Vlassara, H., & ARCHER, D. B. (1998) · PubMed · Cited by 137
Self-citationKadrofske, M. M., Openo, K. P., & Wang, J. L. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0447 · Cited by 135
Pugliese, G., Pricci, F., Romeo, G. R., Pugliese, F. R., Mené, P., Giannini, S., Cresci, B., Galli, G., Rotella, C. M., Vlassara, H., et al. (1997) · Diabetes · doi:10.2337/diab.46.11.1881 · Cited by 135
Self-citationChibber, R., Molinatti, P. A., Rosatto, N., Lambourne, B., & KOHNER, E. M. (1997) · Diabetologia · doi:10.1007/s001250050657 · Cited by 133
Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice
Peppa, Μ., He, C., Hattori, M., McEvoy, R. C., Zheng, F., & Vlassara, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1441 · Cited by 133
Self-citationBiochemical and Molecular Mechanisms in the Development of Diabetic Vascular Complications
King, G. L., Kunisaki, M., Nishio, Y., Inoguchi, T., Shiba, T., & Xia, P. (1996) · Diabetes · doi:10.2337/diab.45.3.s105 · Cited by 130
Hammes, H. P., Brownlee, M., Edelstein, D., Saleck, M., Martin, S., & Federlin, K. (1994) · Diabetologia · doi:10.1007/bf00428774 · Cited by 128
Early impairment of large artery structure and function in Type I diabetes mellitus
Giannattasio, C., Failla, M., Piperno, A., Grappiolo, A., Gamba, P., Paleari, F., & Mancia, G. (1999) · Diabetologia · doi:10.1007/s001250051257 · Cited by 127
Stitt, A. W., He, C., Friedman, S. G., Scher, L. A., Rossi, P., Ong, L., Founds, H., Li, Y. M., Bucala, R., & Vlassara, H. (1997) · Molecular Medicine · doi:10.1007/bf03401819 · Cited by 126
Self-citationBerg, T. J., Bangstad, H. ‐., Torjesen, P. A., Østerby, R., Bucala, R., & Hanssen, K. F. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90010-x · Cited by 124
Pharmacological aspects and therapeutic applications of lysozymes
Sava, G. (1996) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9225-4_22 · Cited by 121
Scavenger Receptors that Recognize Advanced Glycation End Products
Miyazaki, A. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00171-8 · Cited by 113
The maillard or browning reaction in diabetes
John, W. G., & Lamb, E. J. (1993) · Eye · doi:10.1038/eye.1993.55 · Cited by 110
Anti-Glycated Albumin Therapy Ameliorates Early Retinal Microvascular Pathology in db/db Mice
Clements, R. S., Robison, W. G., & Cohen, M. P. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00051-2 · Cited by 109
Selva, M. L., Beltramo, E., Pagnozzi, F., Bena, E., Molinatti, P. A., Molinatti, G. M., & Porta, M. (1996) · Diabetologia · doi:10.1007/s001250050568 · Cited by 106
Scott, S., Loera, S., Tessler, C., Chu, P., Weiss, L. M., Hardy, J. W., Rahbar, S., & Figarola, J. L. (2003) · Diabetologia · doi:10.1007/s00125-003-1162-0 · Cited by 105
Hammes, H. P., Weiss, A., Hess, S., Araki, N., Horiuchi, S., Brownlee, M., & Preissner, K. T. (1996) · PubMed · Cited by 104
Cooper, M. E., Thallas, V., Forbes, J. M., Scalbert, E., Sastra, S. A., Darby, I. A., & Soulis, T. (2000) · Diabetologia · doi:10.1007/s001250051355 · Cited by 102
The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy
Shimoike, T., Inoguchi, T., Umeda, F., Nawata, H., Kawano, K., & Ochi, H. (2000) · Metabolism · doi:10.1053/meta.2000.7738 · Cited by 95
Atherogenesis and Advanced Glycation: Promotion, Progression, and Preventiona
Stitt, A. W., Bucala, R., & Vlassara, H. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51994.x · Cited by 94
Self-citationHe, C., Koschinsky, T., Bünting, C. E., & Vlassara, H. (2001) · Molecular Medicine · doi:10.1007/bf03401949 · Cited by 93
Self-citationHamada, Y., Nakamura, J., Naruse, K., Komori, T., Kato, K., Kasuya, Y., Nagai, R., Horiuchi, S., & Hotta, N. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1539 · Cited by 93
Ellis, E. N., & Good, B. H. (1991) · Metabolism · doi:10.1016/0026-0495(91)90122-d · Cited by 91
Berg, T. J., Clausen, J. T., Torjesen, P. A., Dahl‐Jørgensen, K., Bangstad, H. ‐., & Hanssen, K. F. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1997 · Cited by 90
Sobenin, I. A., Tertov, V. V., Koschinsky, T., Bünting, C. E., Slavina, E. S., Dedov, I. I., & Orekhov, A. N. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90066-4 · Cited by 89
Bucala, R., Model, P., Russel, M., & Cerami, A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8439 · Cited by 88
Elevated glucose 6-phosphate levels are associated with plasmid mutations in vivo.
Lee, A. T., & Cerami, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8311 · Cited by 88
Structural and Functional Changes of Laminin and Type IV Collagen After Nonenzymatic Glycation
CHARONIS, A. S., & Tsilibary, E. C. (1992) · Diabetes · doi:10.2337/diab.41.2.s49 · Cited by 86
He, C., Zheng, F., Stitt, A. W., Striker, L. J., Hattori, M., & Vlassara, H. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00365.x · Cited by 83
Self-citationProduction of Nε-(Carboxymethyl)Lysine Is Impaired in Mice Deficient in NADPH Oxidase
Anderson, M. M., & Heinecke, J. W. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2137 · Cited by 82
Miyata, T., Ishikawa, S., Asahi, K., Inagi, R., Suzuki, D., Horie, K., Tatsumi, K., & Kurokawa, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00122-2 · Cited by 80
Serum levels of low molecular weight advanced glycation end products in diabetic subjects
Sharp, P. S., Rainbow, S. J., & Mukherjee, S. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00973.x · Cited by 79
Advanced Glycation End Products and Their Recognition by Macrophage and Macrophage-Derived Cells
Horiuchi, S., Higashi, T., Ikeda, K., Saishoji, T., Jinnouchi, Y., Sano, H., Shibayama, R., Sakamoto, T., & Araki, N. (1996) · Diabetes · doi:10.2337/diab.45.3.s73 · Cited by 79
Hammes, H., Str�dter, D., Weiss, A., Bretzel, R. G., Federlin, K., & Brownlee, M. (1995) · Diabetologia · doi:10.1007/bf00401835 · Cited by 78
Hyperglycemia, Diabetes, and Vascular Disease
Ruderman, N. B., Williamson, J. R., & Brownlee, M. (1992) · Springer eBooks · doi:10.1007/978-1-4614-7524-8 · Cited by 77
Winkler, G., Pál, B., Nagybégányi, E., Őry, I., Porochnavec, M., & Kempler, P. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300405 · Cited by 76
Vlassara, H., Brownlee, M., & Cerami, A. (1988) · Diabetes · doi:10.2337/diab.37.4.456 · Cited by 76
Self-citationHistones from Diabetic Rats Contain Increased Levels of Advanced Glycation End Products
Gugliucci, A., & Bendayan, M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1935 · Cited by 75
Nakamura, N., Hasegawa, G., Obayashi, H., et al. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00109-8 · Cited by 71
Zheng, F., Cai, W., Mitsuhashi, T., Vlassara, H., & Bucala, R. (2001) · Molecular Medicine · doi:10.1007/bf03401963 · Cited by 70
Self-citationAl‐Abed, Y., Mitsuhashi, T., Li, H., Lawson, J. A., FitzGerald, G. A., Founds, H., Donnelly, T. M., Cerami, A., Ulrich, P. C., & Bucala, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2385 · Cited by 70
Vlassara, H., Moldawer, L. L., & Chan, B. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114366 · Cited by 70
Self-citationTarsio, J. F., Reger, L. A., & Furcht, L. T. (1987) · Biochemistry · doi:10.1021/bi00378a006 · Cited by 69
Sano, H., Higashi, T., Matsumoto, K., Melkko, J., Jinnouchi, Y., Ikeda, K., Ebina, Y., Makino, H., Smedsrød, B. H., & Horiuchi, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8630 · Cited by 68
Mitsuhashi, T., Li, Y. M., Fishbane, S., & Vlassara, H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119600 · Cited by 68
Self-citationGoh, K. C., Lim, Y. P., Ong, S. H., Siak, C. B., Cao, X., Tan, Y. H., & Guy, G. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5832 · Cited by 67
Polymorphism Screening of Four Genes Encoding Advanced Glycation End-Product Putative Receptors
Poirier, O., Nicaud, V., Vionnet, N., Raoux, S., Tarnow, L., Vlassara, H., Parving, H., & Cambien, F. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1214 · Cited by 66
Self-citationRadoff, S., Vlassara, H., & Cerami, A. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90654-6 · Cited by 65
Self-citationTarsio, J. F., Reger, L. A., & Furcht, L. T. (1988) · Diabetes · doi:10.2337/diab.37.5.532 · Cited by 65
Radoff, S., Cerami, A., & Vlassara, H. (1990) · Diabetes · doi:10.2337/diab.39.12.1510 · Cited by 64
Self-citationSuárez, G., Rajaram, R., Bhuyan, K. C., Oronsky, A. L., & Goidl, J. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113641 · Cited by 63
Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit
Panagiotopoulos, S., O’Brien, R. C., Bucala, R., Cooper, M. E., & Jerums, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00192-5 · Cited by 61
Sgarbieri, V. C., Chichester, C. O., Amaya, J., & Tanaka, M. (1973) · Journal of Nutrition · doi:10.1093/jn/103.5.657 · Cited by 60
Cited by
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Advanced glycation endproducts—role in pathology of diabetic complications
Ahmed, N. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.09.004 · Cited by 1,455
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
“There exist strong evidence that under basal conditions AGE-R1/OST-48 and AGE-R3/galectin-3 have a high affinity to bind AGEs [131].”
BackgroundAdvanced glycoxidation end products in commonly consumed foods
Goldberg, T., Cai, W., Peppa, M., Dardaine, V., Baliga, B. S., Uribarri, J., & Vlassara, H. (2004) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.05.214 · Cited by 744
“dvanced glycoxidation end products (AGEs) constitute a group of heterogeneous moieties produced endogenously from the nonenzymatic glycation of proteins, lipids, and nucleic acids ( 1 ,2).”
BackgroundSelf-citation
Metadata
- Authors
- Vlassara, H., & Palace, M. R.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2002-02
- Volume
- 251
- Issue
- 2
- Pages
- 87-101
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2084536221
- Cited by
- 697
- References
- 221
- FWCI
- 22.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.